Rtw Investments, LP Vincerx Pharma, Inc. Transaction History

Rtw Investments, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.0 - $0.0 $0 - $0	-741,236 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.0 - $0.0 $0 - $0	-8,763 Reduced 1.17%	741,236 $7.55 Million
Q2 2021 Aug 13, 2021	BUY	$0.0 - $27.0 $0 - $6.75 Million	249,999 Added 50.0%	749,999 $9.74 Million
Q4 2020 Feb 16, 2021	BUY	$12.85 - $19.95 $6.43 Million - $9.98 Million	500,000 New	500,000 $10.5 Million

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.